Affimed (AFMD) analysis deep-dive
Locking in profits but also buying more
AFMD has really taken off after using natural killer (NK) cells sourced from umbilical cords to target cancer. Cell therapy, at least in cancer, seems to be the craze nowadays (if you’re new to AFMD, you can start here for a brief overview). Overall, the NK space is hot and AFMD has had a nice move after languishing around $2-3 for years. AFMD’s stro…